Fresenius Medical Care AG & Co. KGaA

General ticker "FMCQF" information:

  • Sector: Health Care
  • Industry: Medical - Care Facilities
  • Capitalization: $14.8B (TTM average)

Fresenius Medical Care AG & Co. KGaA follows the US Stock Market performance with the rate: 15.6%.

Estimated limits based on current volatility of 0.1%: low 46.62$, high 46.73$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-05-26, amount 1.62$ (Y3.48%)
  • Total employees count: 47521 as of 2005
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [41.90$, 60.02$]
  • 2025-12-31 to 2026-12-31 estimated range: [43.78$, 62.88$]

Financial Metrics affecting the FMCQF estimates:

  • Negative: with PPE of 22.8 at the end of fiscal year the price was very high
  • Positive: -3.60 < Operating profit margin, % of 7.20
  • Positive: Operating cash flow per share per price, % of 18.66 > 13.24
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: -8.75 < Industry operating profit margin (median), % of -3.16
  • Positive: 41.86 < Shareholder equity ratio, % of 43.43 <= 63.39
  • Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.16
  • Negative: Investing cash flow per share per price, % of -0.66 <= -0.66
  • Negative: Industry earnings per price (median), % of 0 <= 0
  • Negative: 0.79 < Interest expense per share per price, % of 3.18

Similar symbols

Short-term FMCQF quotes

Long-term FMCQF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue €19,398.00MM €19,453.62MM €19,335.91MM
Operating Expenses €17,886.24MM €18,084.18MM €17,943.51MM
Operating Income €1,511.76MM €1,369.44MM €1,392.39MM
Non-Operating Income €-292.48MM €-336.42MM €-335.47MM
Interest Expense €360.14MM €424.64MM €407.04MM
R&D Expense €228.62MM €231.97MM €183.49MM
Income(Loss) €1,219.28MM €1,033.02MM €1,056.93MM
Taxes €324.95MM €300.56MM €316.06MM
Profit(Loss)* €673.40MM €499.00MM €537.91MM
Stockholders Equity €15,449.00MM €13,620.26MM €14,576.56MM
Inventory €2,296.21MM €2,179.18MM €2,067.92MM
Assets €35,754.00MM €33,929.81MM €33,566.58MM
Operating Cash Flow €2,167.00MM €2,628.80MM €2,386.14MM
Capital expenditure €1,411.00MM €684.60MM €699.36MM
Investing Cash Flow €-734.73MM €-544.23MM €-84.94MM
Financing Cash Flow €-1,617.36MM €-1,858.53MM €-2,569.30MM
Earnings Per Share** €2.30 €1.70 €1.83

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.